Celgene

Celgene Pharmaceutical is a major international research biomedical pharmaceutical conglomerate that has pioneered the development and introduction of cutting-edge cancer medications and immunity inflammatory regimens. Drug compounds developed by its research teams, at any one time more than 100, are regularly being tested in clinical trials in the United States and overseas. Forbes ranks it as the second-most profitable drug company in the world. Celgene has faced industrywide charges of price gauging and interfering with the development of alternative, less-expensive, so-called generic replacement drugs. In 2009, Celgene was sued by a private research company that claimed it had blocked access to research work, thus disabling attempts to create generic replacement drugs of its major products. Celgene countered with the claim that without its control of ...